GenEng News  Mar 7  Comment 
Roivant Sciences will partner with Ligand Pharmaceuticals to codevelop its type 2 diabetes candidate LGD-6972 through a collaboration that could generate up to $533.8 million for Ligand—and is aimed at developing the second pipeline candidate of...
GenEng News  Feb 23  Comment 
Scientists from Johns Hopkins, using software from Insilico Medicine, say they have invented a new class of immunotherapeutics to fight cancer. The team published its study (“ Bifunctional Immune Checkpoint-Targeted Antibody-Ligand Traps That...
Benzinga  Feb 21  Comment 
On Wednesday, Ligand Pharmaceuticals (NASDAQ: LGND) will release its latest earnings report. Here is Benzinga's outlook for the company. Earnings and Revenue Based on Ligand management projections, analysts predict EPS of $1.14 on revenue of...
SeekingAlpha  Jan 30  Comment 

You may also be interested in articles related to Ligand Pharmaceuticals (LGND):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki